Literature DB >> 9365168

Human testicular germ cell tumours express inhibin subunits, activin receptors and follistatin mRNAs.

R H van Schaik1, C D Wierikx, L H Looijenga, J W Oosterhuis, F H de Jong.   

Abstract

Germ cell development is influenced by activin and inhibin, which are produced by Sertoli cells. Activin also affects differentiation of mouse embryonal carcinoma cells, which, to a certain extent, resemble the embryonal carcinoma component of germ cell tumours. Therefore, the expression of inhibin/activin subunits, of activin receptors and of the activin-binding protein follistatin was studied in testicular germ cell tumours, using RNAase protection assays. Testicular germ cell tumours of adolescents and adults (TGCTs) and spermatocytic seminomas expressed activin type I and type II receptors (ActRI and ActRII respectively). Seminomas expressed significantly lower levels of ActRIIA (P<0.05, Mann-Whitney U-test) and higher levels of ActRIA (P<0.05) and ActRIB (P<0.05) compared with non-seminomas. All tumours expressed inhibin beta-subunit transcripts, which are a prerequisite for activin synthesis. Non-seminomas contained significantly higher levels of the inhibin betaA subunit (P<0.001) compared with seminomas. No activin betaC subunit transcripts could be demonstrated by RNAase protection. Inhibin alpha-subunit expression was absent in the spermatocytic seminomas, in six out of nine seminomas and in 10 out of 11 non-seminomas. Follistatin was expressed predominantly in non-seminomas and spermatocytic seminomas. This expression of activin type I and type II receptors in combination with expression of inhibin beta-subunits indicates that activin may act as a para- or autocrine factor in the regulation of growth and differentiation of tumours of human germ cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9365168      PMCID: PMC2228115          DOI: 10.1038/bjc.1997.532

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  54 in total

1.  Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-beta.

Authors:  A J Mason; J S Hayflick; N Ling; F Esch; N Ueno; S Y Ying; R Guillemin; H Niall; P H Seeburg
Journal:  Nature       Date:  1985 Dec 19-1986 Jan 1       Impact factor: 49.962

2.  Expression of activin beta C subunit mRNA in reproductive tissues.

Authors:  K L Loveland; J R McFarlane; D M de Kretser
Journal:  J Mol Endocrinol       Date:  1996-08       Impact factor: 5.098

3.  Evidence for inhibin-like activity in bovine follicular fluid.

Authors:  F H De Jong; R M Sharpe
Journal:  Nature       Date:  1976-09-02       Impact factor: 49.962

4.  Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin.

Authors:  N Ling; S Y Ying; N Ueno; S Shimasaki; F Esch; M Hotta; R Guillemin
Journal:  Nature       Date:  1986 Jun 19-25       Impact factor: 49.962

5.  Inhibin A-subunit cDNAs from porcine ovary and human placenta.

Authors:  K E Mayo; G M Cerelli; J Spiess; J Rivier; M G Rosenfeld; R M Evans; W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

6.  Nucleotide sequence of the human gamma cytoskeletal actin mRNA: anomalous evolution of vertebrate non-muscle actin genes.

Authors:  H P Erba; P Gunning; L Kedes
Journal:  Nucleic Acids Res       Date:  1986-07-11       Impact factor: 16.971

Review 7.  Pathology of germ cell tumors of testis: a progress report.

Authors:  F K Mostofi
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

8.  Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid.

Authors:  W Vale; J Rivier; J Vaughan; R McClintock; A Corrigan; W Woo; D Karr; J Spiess
Journal:  Nature       Date:  1986 Jun 19-25       Impact factor: 49.962

9.  Spermatocytic seminoma: clinicopathological study of 22 cases.

Authors:  A Talerman
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

10.  The spermatocytic seminoma: views on pathogenesis.

Authors:  J Müller; N E Skakkebaek; M C Parkinson
Journal:  Int J Androl       Date:  1987-02
View more
  2 in total

1.  Genetic variation in the inhibin pathway and risk of testicular germ cell tumors.

Authors:  Mark P Purdue; Barry I Graubard; Stephen J Chanock; Mark V Rubertone; Ralph L Erickson; Katherine A McGlynn
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

2.  Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues.

Authors:  R H van Schaik; C D Wierikx; M A Timmerman; M H Oomen; W M van Weerden; T H van der Kwast; G J van Steenbrugge; F H de Jong
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.